From: Prospective virtual screening combined with bio-molecular simulation enabled identification of new inhibitors for the KRAS drug target
Model
Accuracy
Sensitivity
Specificity
MCC
Precision
Recall
KNN
94%
0.95
0.94
0.82
0.74
0.86
SVM
0.92
0.84
0.83
0.90
RF
98%
0.96
0.99
0.97
GNB
92%
0.85
0.77
0.70